169 related articles for article (PubMed ID: 67211)
61. Increased lymphocyte-mediated destruction of tumor cells in microcytotoxicity assays seen after addition of inhibitors of protein synthesis.
Hellström I; Hellström KE; Nepom JT
Int J Cancer; 1975 Nov; 16(5):830-9. PubMed ID: 1184246
[TBL] [Abstract][Full Text] [Related]
62. Antigenic differences between primary methylcholanthrene-induced rat sarcomas and post-surgical recurrences.
Pimm MV; Baldwin RW
Int J Cancer; 1977 Jul; 20(1):37-43. PubMed ID: 71272
[TBL] [Abstract][Full Text] [Related]
63. An in vitro immuno-enzymatic assay of tumor antigens in the mouse with beta-galactosidase.
Celada F; Natali PG; Radojkovic J
J Immunol; 1976 Sep; 117(3):904-10. PubMed ID: 784874
[TBL] [Abstract][Full Text] [Related]
64. Anomalous reactions of mouse alloantisera with cultured tumor cells. I. Demonstration of widespread occurrence using reference typing sera.
Klein PA
J Immunol; 1975 Nov; 115(5):1254-60. PubMed ID: 51886
[TBL] [Abstract][Full Text] [Related]
65. Development of a simplified isotopic antiglobulin assay for the study of tumor-specific antibody.
Burdick JF; Wells SA; Cohen AM; Ketcham AS
J Surg Res; 1973 Mar; 14(3):200-6. PubMed ID: 4540803
[No Abstract] [Full Text] [Related]
66. Heterogeneity of KCl-solubilized antigens of chemically induced sarcomas.
Blackstock R; Schimpff RD; Smith RT
Proc Soc Exp Biol Med; 1978 Mar; 157(3):354-7. PubMed ID: 76314
[No Abstract] [Full Text] [Related]
67. Serologic analysis of human tumor antigens. II. Reactivity of sera from eleven osetogenic sarcoma patients against autologous and allogeneic tumor cells.
Rosenberg SA; Tondreau SC; Shoffner PC; Hyatt C; Brown JM; Thorpe W; Sindelar W
Surgery; 1979 Aug; 86(2):258-65. PubMed ID: 288177
[TBL] [Abstract][Full Text] [Related]
68. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers.
Parmiani G; Carbone G; Lembo R
Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474
[No Abstract] [Full Text] [Related]
69. Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity.
Chou T; Chang AE; Shu SY
J Immunol; 1988 Apr; 140(7):2453-61. PubMed ID: 2450925
[TBL] [Abstract][Full Text] [Related]
70. Cell-mediated suppression of tumor immunity has a non-specific component. II. Evidence from cell culture experiments.
Hellström I; Hellström KE
Int J Cancer; 1981; 27(4):487-91. PubMed ID: 6168592
[TBL] [Abstract][Full Text] [Related]
71. Syngeneic monoclonal antibodies to a methylcholanthrene-induced mouse sarcoma.
Lennox E; Cohn J; Lowe T
Transplant Proc; 1980 Mar; 12(1):95-8. PubMed ID: 7368297
[No Abstract] [Full Text] [Related]
72. In vitro generation of primary and secondary cytotoxic cell-mediated immune responses to chemically induced mouse sarcomas.
Kall MA; Hellström I; Hellström KE
Int J Cancer; 1976 Oct; 18(4):488-97. PubMed ID: 977191
[TBL] [Abstract][Full Text] [Related]
73. Distinct immunologic specificity of tumor regression mediated by effector cells isolated from immunized and tumor-bearing mice.
Chang AE; Perry-Lalley DM; Shu S
Cell Immunol; 1989 May; 120(2):419-29. PubMed ID: 2785860
[TBL] [Abstract][Full Text] [Related]
74. Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumors.
Civin CI; Dorfman N; Eggers A; Fink K; Penvose D; Hsu CK; Wunderlich JR
J Immunol; 1979 Dec; 123(6):2550-7. PubMed ID: 159318
[TBL] [Abstract][Full Text] [Related]
75. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
Tamerius JD; Hellström I
J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
[No Abstract] [Full Text] [Related]
76. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines.
Edelman AS; Xue B; Sanchez P; Thorbecke GJ
J Immunol; 1985 Sep; 135(3):2206-12. PubMed ID: 3926898
[TBL] [Abstract][Full Text] [Related]
77. Antibody production by spleen cells of mice bearing MCA-induced tumours: search for suppressor cells.
Yagello M; Lespinats G; Fridman WH
Int J Cancer; 1978 Aug; 22(2):136-41. PubMed ID: 359487
[TBL] [Abstract][Full Text] [Related]
78. Loss of marrow allograft resistance in mice with transplanted methylcholanthrene-induced sarcomas.
Kumar V; Bennett M
J Natl Cancer Inst; 1975 Aug; 55(2):489-92. PubMed ID: 240033
[TBL] [Abstract][Full Text] [Related]
79. Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens.
Hanna MG; Ihle JN; Batzing BL; Tennant TW; Schenley CK
Cancer Res; 1975 Jan; 35(1):164-71. PubMed ID: 45890
[TBL] [Abstract][Full Text] [Related]
80. Foetal antigens cross-reactive with tumour-specific transplantation antigens.
LeMevel BP; Wells SA
Nat New Biol; 1973 Aug; 244(136):183-4. PubMed ID: 4516453
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
